Goettingen - Start of a new trial site

Today, the Göttingen University Medical Center, Georg-August University became officially an active trial site of the STOP-PKD Study.

The team of Prof. Dr. Oliver Gross cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Göttingen to obtain detailed information about the trial and potential participation.

Phone: +49 551 – 39 62242

Email: carmen.scherf@med.uni-goettingen.de